(Q84075126)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Kai-Ping Chang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Ya-Ting Chang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yu-Ling Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Min-Chi Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Ngan-Ming Tsang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Cheng-Lung Hsu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yu-Sun Chang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Jau-Song Yu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

29 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

886-897

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy

31 January 2020

cites work

1 reference

7 January 2021

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival

1 reference

7 January 2021

The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma.

1 reference

7 January 2021

Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure

1 reference

7 January 2021

Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification

1 reference

7 January 2021

Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

1 reference

7 January 2021

Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma

1 reference

7 January 2021

Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma

1 reference

7 January 2021

Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma

1 reference

7 January 2021

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma

1 reference

7 January 2021

Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma.

1 reference

7 January 2021

Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma

1 reference

7 January 2021

1 reference

7 January 2021

Chemokines in neoplastic progression

1 reference

7 January 2021

Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

1 reference

7 January 2021

Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells

1 reference

7 January 2021

Clinical implications of the serum level of CD23 in patients with undifferentiated nasopharyngeal carcinoma

1 reference

7 January 2021

Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients.

1 reference

7 January 2021

Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma

1 reference

7 January 2021

The significance of serum soluble intercellular adhesion molecule 1 and transforming growth factor alpha in patients with nasopharyngeal carcinoma

1 reference

7 January 2021

Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma

1 reference

7 January 2021

Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes

1 reference

7 January 2021

Cytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patients

1 reference

7 January 2021

Interferon-gamma secretion and perforin expression are impaired in CD8+ T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal type

1 reference

7 January 2021

Human regulatory CD8 T cells

1 reference

7 January 2021

Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China

1 reference

7 January 2021

Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro

1 reference

7 January 2021

Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma

1 reference

7 January 2021

Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression

1 reference

7 January 2021

Expression of the interferon-inducible chemokine IP-10 (CXCL10), a chemokine with proposed anti-neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinoma.

1 reference

7 January 2021

New TNM staging criteria for head and neck tumors

1 reference

7 January 2021

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

7 January 2021

Comparison of multiplex immunoassay platforms

1 reference

7 January 2021

Serum protein markers for early detection of ovarian cancer

1 reference

7 January 2021

Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling.

1 reference

7 January 2021

Serum levels of CYFRA 21-1 in nasopharyngeal carcinoma and its possible role in monitoring of therapy.

1 reference

7 January 2021

Cancer diagnosis using proteomic patterns

1 reference

7 January 2021

Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1.

1 reference

7 January 2021

Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells

1 reference

7 January 2021

The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: importance of mRNA half-life regulation

1 reference

7 January 2021

Expression of interleukin-8 receptor A predicts poor outcome in patients with nasopharyngeal carcinoma

1 reference

7 January 2021

Endoplasmic reticulum stress triggers XBP-1-mediated up-regulation of an EBV oncoprotein in nasopharyngeal carcinoma

1 reference

7 January 2021

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

1 reference

7 January 2021

Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21557

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21560180%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference